Showing all 2 results

  • Ibuprofen
    Mb-fen Suspension 60ml


    Each 5ml
    Ibuprofen Suspension B.P.100mg


    Rheumatic Diseases such as:
    Rheumatoid arthritis, Osteoarthritis, Ankylosing Spondylitis, Juvenile rheumatoid arthritis. Pain and inflammation following dental or obstetric surgery, acute gouty arthritis, Painful non-rheumatic inflammatory conditions such as athletic injuries strains or sprains), Bursitis, capsulitis, synovitis, Tendinitis or tenosynovitis. For reduction of fever. For the relief of pain associated with the primary dysmenorrheoa.


    Fever Reduction:
    For reduction of fever in children, 6 months up to 2 years of age, the dosage should be adjusted on the basis of the initial temperature level.  The recommended dose is 5 mg/kg if the baseline temperature is less than 102.5°F, or 10 mg/kg if the baseline temperature is 102.5°F or greater. The duration of fever reduction is generally 6 to 8 hours. The recommended maximum daily dose is 40 mg/kg.Analgesia:
    For relief of mild to moderate pain in children 6 months up to 2 years of age, the recommended dosage is 10 mg/kg, every 6 to 8 hours. The recommended maximum daily dose is 40 mg/kg. Doses should be given so as not to disturb the child's sleep pattern.Juvenile Arthritis:
    The recommended dose is 30 to 40 mg/kg/day divided into three to four doses (see INDIVIDUALIZATION OF DOSAGE ). Patients with milder disease may be adequately treated with 20 mg/kg/day.
    In patients with juvenile arthritis, doses above 50 mg/kg/day are not recommended because they have not been studied and doses exceeding the upper recommended dose of 40 mg/kg/day may increase the risk of causing serious adverse events. The therapeutic response may require from a few days to several weeks to be achieved. Once a clinical effect is obtained, the dosage should be lowered to the smallest dose of ibuprofen needed to maintain adequate control of symptoms. Pediatric patients receiving doses above 30 mg/kg/day or if abnormal liver function tests have occurred with previous NSAID treatments should be carefully followed for signs and symptoms of early liver dysfunction.


    Primary Dysmenorrhea:
    For the treatment of primary dysmenorrhea, beginning with the earliest onset of such pain, Ibuprofen Oral Suspension should be given in a dose of 400 mg every 4 hours, as necessary, for the relief of pain.

    Rheumatoid Arthritis and Osteoarthritis:
    Suggested dosage: 1200-3200 mg daily (300 mg q.i.d. or 400 mg, 600 mg or 800 mg t.i.d. or q.i.d.). Individual patients may show a better response to 3200 mg daily, as compared with 2400 mg, although in well-controlled clinical trials patients on 3200 mg did not show a better mean response in terms of efficacy. Therefore, when treating patients with 3200 mg/day, the physician should observe sufficient increased clinical benefits to offset potential increased risk.

    Individualization of Dosage:

    The dose of Ibuprofen Oral Suspension should be tailored to each patient, and may be lowered or raised from the suggested doses depending on the severity of symptoms either at time of initiating drug therapy or as the patient responds or fails to respond. One fever study showed that, after the initial dose of ibuprofen oral suspension, subsequent doses may be lowered and still provide adequate fever control. In a situation when low fever would require the ibuprofen oral suspension 5 mg/kg dose in a child with pain, the dose that will effectively treat the predominant symptom should be chosen. In chronic conditions, a therapeutic response to ibuprofen oral suspension therapy is sometimes seen in a few days to a week, but most often is observed by two weeks. After a satisfactory response has been achieved, the patient's dose should be reviewed and adjusted as required.

  • Ibuprofen 400mg
    Mb-fen Tablet 10*20's


    Ibuprofen B.P  400mg


    Mb-fen is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still's disease), ankylosing spondylitis, osteoarthritis and other non-rheumatoid (seronegative) arthropathies. In the treatment of non-articular rheumatic conditions, Mb-fen is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis and low back pain; Mb-fen can also be used in soft tissue injuries such as sprains and strains. Mb-fen is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache, including migraine headache.

    Dosage and Administration:

    Adults and children over 12 years of age: The recommended dosage of Mb-fen is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. In severe or acute conditions, it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the total daily dose does not exceed 2400 mg in divided doses.


    The daily dosage of Mb-fen is 20 mg/kg of body weight in divided doses.
    In Juvenile Rheumatoid Arthritis, up to 40 mg/kg of body weight daily in divided doses may be taken.
    Elderly: The elderly are at increased risk of serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy. If renal or hepatic function is impaired, dosage should be assessed individually.
    For oral administration. It is recommended that patients with sensitive stomachs take Mb-fen with food. If taken shortly after eating, the onset of action of Mb-fen may be delayed. To be taken preferably with or after food, with plenty of fluid. Mb-fen tablets should be swallowed whole and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation.